Flavones have received considerable attention because of their antiproliferative properties and selective effects on cancer cells, making them good candidates for use in cancer therapy. In contrast to other flavones, little is known about the effects of the flavone core structure (2-phenyl-4H-1-benzopyran-4one) on cancer cells. Here, we report that flavone induces cell death in human hepatoma HepG2 cells. Furthermore, annexin-V+/PI- and SubG1 populations of HepG2 cells increased after flavone treatment. Exposure of HepG2 to flavone did not result in either cytochrome c release into the cytosol or changes in the mitochondrial membrane potential. Treatment of HepG2 cells with flavone for 24 h reduced the accumulation of intracellular ROS, which correlated with upregulation of Gred, CuZnSOD and MnSOD mRNA levels. Taken together, our results provided useful insights into the mechanism of cell death caused by flavones, in order to evaluate their future application in hepatocarcinoma therapy.
ChaC.H., SaifM.W., YamaneB.H., WeberS.M. (2010) Hepatocellular carcinoma: Current management. Current Problems in Surgery, 47, 10–67.
3.
BlumH.E. (2005) Treatment of hepatocellular carcinoma. Best Practice & Research in Clinical Gastroenterology, 19, 129–145.
4.
MontoroP., BracaA., PizzaC., De TommasiN. (2005) Structure-antioxidant activity relationships of flavonoids isolated from different plant species. Food Chemistry, 92, 349–355.
5.
SunL., ZhangJ., LuX., ZhangL., ZhangY. (2011) Evaluation of the antioxidant activity of total flavonoids extract from persimmon (Diospyros kaki L.) leaves. Food and Chemical Toxicology, 49, 2689–2696.
6.
MiddletonE., KandaswamiC., TheoharidesT.C. (2000) The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacological Reviews, 52, 673–751.
7.
Ahmed-BelkacemA., PozzaA., Muñoz-MartínezF., BatesS.E., CastanysS., GamarroF., Di PietroA., Pérez-VictoriaJ.M. (2005) Flavonoid structure-activity studies identify 6-prenyichrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. Cancer Research, 65, 4852–4860.
8.
BoumendjelA., MacalouS., ValdameriG., PozzaA., GauthierC., ArnaudO., NicolleE., MarnargS., FalsonP., TerreuxR., CarruptP.A., PayenL., Di PietroA. (2011) Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: In vitro optimization and in vivo validation. Current Medicinal Chemistry, 18, 3387–3401.
9.
ShuklaS., GuptaS. (2008) Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radical Biology & Medicine, 44, 1833–1845.
10.
ShuklaS., GuptaS. (2010) Apigenin: A promising molecule for cancer prevention. Pharmaceutical Research, 27, 962–978.
11.
ZhangQ., ZhaoX-H, WangZ-J. (2008) Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food and Chemical Toxicology, 46, 2042–2053.
12.
ValdameriG., Trombetta-LimaM., WorfelP.R., PiresA.R., MartinezG.R., NoletoG.R., CadenaS.M.S., SogayarM.C., WinnischoferS.M.B., RochaM.E.M. (2011) Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells. Chemico-Biological Interactions, 193, 180–189.
13.
ValdameriG., HerreriasT., CarnieriE.G.S., CadenaS., MartinezG.R., RochaM.E.M. (2010) Importance of the core structure of flavones in promoting inhibition of the mitochondrial respiratory chain. Chemico-Biological Interactions, 188, 52–58.
14.
BaiF.L., MatsuiT., Ohtani-FujitaN., MatsukawaY., DingY., SakaiT. (1998) Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G(1) phase arrest in A549 lung adenocarcinoma cells. FEBS Letters, 437, 61–64.
15.
WenzelU., KuntzS., BrendelM.D., DanielH. (2000) Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Research, 60, 3823–3831.
16.
WenzelU., NickelA., DanielH. (2005) Increased mitochondrial palmitoylcarnitine/carnitine countertransport by flavone causes oxidative stress and apoptosis in colon cancer cells. Cellular and Molecular Life Sciences, 62, 3100–3105.
17.
UllmannovaV., PopescuN.C. (2007) Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detection and Prevention, 31, 110–118.
18.
YadegaryniaS., PhamA., NgA., NguyenD., LialiutskaT., BortolassoA., SivryukV., BremerM., WhiteJ.B. (2012) Profiling flavonoid cytotoxicity in human breast cancer cell lines: determination of structure-function relationships. Natural Product Communications, 10, 1295–304.
19.
KasibhatlaS., TsengB. (2003) Why target apoptosis in cancer treatment?Molecular Cancer Therapeutics, 2, 573–580.
20.
KuengW., SilberE., EppenbergerU. (1989) Quantification of cells cultured on 96-well plates. Analytical Biochemistry, 182, 16–19.
21.
AppaixF., MinatchyM.N., Riva-LavieilleC., OlivaresJ., AntonssonB., SaksV.A. (2000) Rapid spectrophotometric method for quantitation of cytochrome c release from isolated mitochondria or permeabilized cells revisited. Biochimica et Biophysica Acta - Bioenergetics, 1457, 175–181.
22.
KrishanA. (1975) Rapid flow cytofluorometric analysis of mammalian-cell cycle by propidium iodide staining. Journal of Cell Biology, 66, 188–193.
23.
EruslanovE., KusmartsevS. (2010) Identification of ROS using oxidized DCFDA and flow-cytometry. In Advanced Protocols in Oxidative Stress II. Methods in Molecular Biology. Armstrong D. (Ed.)., 594, 57–72.
24.
BradfordM.M. (1976) Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Analytical Biochemistry, 72, 248–254.
